Résumé
Objective To explore the characteristics of dipyridamole 201 Tl myocardial perfusion imaging (MPI) SPECT in patients with dilated cardiomyopathy. Methods Thirty patients with dilated cardiomyopathy underwent pharmacological stress 201Tl MPI SPECT after intravenous infusion of dipyridamole (0. 56 mg/kg) for 4 min. The early and delayed SPECT images were acquired respectively at 10 and 240 min after 201Tl injection. The images were analyzed and reported by two or three experienced nuclear medicine physicians. Results All patients were found to have abnormal perfusion patterns at delay imaging, however 90.00% (27/30) were also abnormal at early images. Six patients had reverse redistribution. Conclusion Dipyridamole 201Tl MPI SPECT imaging may be of some value for the assessment of patients with dilated cardiomyopathy.
Résumé
<p><b>OBJECTIVE</b>To compare the value of dipyridamole (201)Tl Single photon emission computed tomography (SPECT) myocardial imaging and exercise myocardial (99)Tc(m)-MIBI SPECT imaging on diagnosing cardiac syndrome X.</p><p><b>METHODS</b>Sixty-three patients with known cardiac syndrome X were divided into dipyridamole (201)Tl SPECT myocardial imaging group (group 1, n = 35) and exercise myocardial (99)Tc(m)-MIBI-SPECT imaging group (group 2, n = 28) and the diagnostic accuracy rates were compared.</p><p><b>RESULTS</b>Thirty-one out of 35 cardiac syndrome X patients showed reverse redistribution in group 1 and the diagnostic accuracy rate was 89%. Positive test results were evidenced 24 out of 28 cardiac syndrome X patients in group 2 and the diagnostic accuracy rate was 87% (P > 0.05 vs. group 1).</p><p><b>CONCLUSION</b>The diagnostic accuracy rates of these two myocardial imaging methods were satisfactory and comparable on detecting cardiac syndrome X.</p>